NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Purple Biotech Ltd (TA: KTOV)

 
KTOV Technical Analysis
5
As on 14th Sep 2025 KTOV STOCK Price closed @ 1.10 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 13.45 & Strong Sell for SHORT-TERM with Stoploss of 23.09 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

KTOVSTOCK Price

Open 1.10 Change Price %
High 1.10 1 Day 0.10 10.00
Low 1.00 1 Week -1.20 -52.17
Close 1.10 1 Month -2.70 -71.05
Volume 4668450 1 Year -27.10 -96.10
52 Week High 34.40 | 52 Week Low 1.10
 
TA Israel Most Active Stocks
TA125 2008.05 1.06%
GODM 59.20 11.70%
KTOV 1.10 10.00%
PPBT 1.10 10.00%
AMX 12.70 -1.55%
ORL 86.30 -2.60%
BLRX 2.20 -4.35%
BEZQ 631.50 -2.64%
TDGN-L 171.50 17.55%
BONS 24.50 -2.00%
 
TA Israel Top Gainers Stocks
HROD 7210.00 29.93%
INBR 348.00 19.18%
ITYF 348.00 19.18%
TDGN-L 171.50 17.55%
MCRNT 372.50 16.84%
NZHT 64.00 14.49%
LZNR 64.00 14.49%
GODM 59.20 11.70%
CNMD 45.10 10.54%
CNMD 45.10 10.54%
 
TA Israel Top Losers Stocks
KMNK 51.00 -23.19%
ULTR 74.10 -16.74%
MMHD 29020.00 -13.55%
ALMO 2450.00 -11.39%
GIX 2450.00 -11.39%
GIX 2450.00 -11.39%
HARL 10060.00 -11.05%
HARL 10060.00 -11.05%
MEAT 0.77 -9.41%
MEAT 0.77 -9.41%
 
 
KTOV
Daily Charts
KTOV
Intraday Charts
Whats New @
Bazaartrend
KTOV
Free Analysis
 
KTOV Important Levels Intraday
RESISTANCE1.29
RESISTANCE1.23
RESISTANCE1.19
RESISTANCE1.15
SUPPORT1.05
SUPPORT1.01
SUPPORT0.97
SUPPORT0.91
 
KTOV Forecast September 2025
4th UP Forecast18.83
3rd UP Forecast13.14
2nd UP Forecast9.63
1st UP Forecast6.11
1st DOWN Forecast-3.91
2nd DOWN Forecast-7.43
3rd DOWN Forecast-10.94
4th DOWN Forecast-16.63
 
KTOV Weekly Forecast
4th UP Forecast10.35
3rd UP Forecast7.38
2nd UP Forecast5.55
1st UP Forecast3.72
1st DOWN Forecast-1.52
2nd DOWN Forecast-3.35
3rd DOWN Forecast-5.18
4th DOWN Forecast-8.15
 
KTOV Forecast2025
4th UP Forecast70.09
3rd UP Forecast47.96
2nd UP Forecast34.29
1st UP Forecast20.61
1st DOWN Forecast-18.41
2nd DOWN Forecast-32.09
3rd DOWN Forecast-45.76
4th DOWN Forecast-67.89
 
 
KTOV Other Details
Segment EQ
Market Capital 227007808.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
KTOV Address
KTOV
 
KTOV Latest News
 
Your Comments and Response on Purple Biotech Ltd
 
KTOV Business Profile
Purple Biotech Ltd., a clinical-stage pharmaceutical company, focuses on the development and commercialization of various pharmaceutical drugs. It operates through two segments, Oncology, and Pain and Hypertension. The company's marketed products include Consensi, a fixed-dose combination of celecoxib and amlodipine besylate for the simultaneous treatment of osteoarthritis pain and hypertension in the United States, as well as in China and South Korea. Its oncology pipeline includes NT-219, a small molecule that is advancing as a monotherapy treatment of advanced solid tumors and in combination with cetuximab for the treatment of recurrent or metastatic squamous cell carcinoma of head and neck cancer in a planned phase 1/2 study; and CM-24, a monoclonal antibody blocking CEACAM1 that is being developed as a combination therapy with anti-PD1 checkpoint inhibitors for the treatment of non-small cell lung cancer and pancreatic cancer. The company was formerly known as Kitov Pharma Ltd and changed its name to Purple Biotech Ltd. in December 2020. Purple Biotech Ltd. is headquartered in Tel Aviv, Israel. Address: One Azrieli Center, Tel Aviv, Israel, 6701101
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service